News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Muscular Dystrophy Association Awards $120,000 to Catabasis Pharmaceuticals, Inc.


4/4/2012 9:51:57 AM

TUCSON, Ariz., & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Muscular Dystrophy Association announced today that it has awarded $120,000 to Cambridge, Mass.-based Catabasis Pharmaceuticals as part of a strategic partnership under which the biopharmaceutical company will test two compounds called CAT-1004 and CAT-1040 in the mdx research mouse model of Duchenne muscular dystrophy (DMD).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES